iBio files updated corporate presentation; no financial details in filing

iBio, Inc.

Company furnished a new investor presentation dated January 2024 as Exhibit 99.1.
Presentation title emphasizes precision antibody therapeutics and machine learning.
No specific financial metrics, guidance, or operational updates disclosed in the filing text.

item 7.01 item 9.01

iBio, Inc. filing history →

Source: SEC EDGAR

accession 0001420720-24-000002

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.